ArticleClinical journal of gastroenterology2026
Disseminated nocardiosis involving lung, liver, and spleen in a patient with intestinal Behçet's disease under combined immunosuppressive therapy.
Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a rare case of disseminated nocardiosis in a woman in her 50 s with a 20-year history of intestinal Behçet's disease who had been receiving infliximab, azathioprine, and oral betamethasone. She developed fever and sore throat 6 weeks after infliximab administration. Laboratory findings revealed leukocytosis, elevated liver enzymes, and markedly increased C-reactive protein and procalcitonin. Contrast-enhanced computed tomography revealed multiple nodular lesions in both lungs and multiple abscesses in the liver and spleen. Blood cultures identified Nocardia species, and a diagnosis of disseminated nocardiosis was established. Initial treatment with trimethoprim-sulfamethoxazole was discontinued because of drug-induced pancreatitis. The regimen was switched to imipenem/cilastatin, followed by minocycline, resulting in complete abscess resolution. A literature review identified three similar cases with lung, liver, and splenic abscesses, all with significant T-cell-related immunosuppression. This case highlights the risk of disseminated Nocardia infection in patients receiving combined immunosuppressive therapy, including biologics, and highlights the importance of early diagnosis and adaptable antimicrobial management in immunocompromised hosts.
Indexed as
Identifiers
41014470What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.